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Abstract An integrated microfluidic system that coupled
lysis of two cell lines: L929 fibroblasts and A549 epithelial
cells, with fluorescence-based enzyme assay was developed
to determine β-glucocerebrosidase activity. The micro-
device fabricated in poly(dimethylsiloxane) consists of
three main parts: a chemical cell lysis zone based on the
sheath flow geometry, a micromeander and an optical fibers
detection zone. Unlike many methods described in litera-
ture that are designed to analyse intracellular components,
the presented system enables to perform enzyme assays just
after cell lysis process. It reduces the effect of proteases
released in lysis process on determined enzymes. Glucocer-
ebrosidase activity, the diagnostic marker for Gaucher’s
disease, is the most commonly measured in leukocytes and
fibroblasts using 4-methylumbelliferyl-β-D-glucopyranoside
as synthetic β-glucoside. The enzyme cleavage releases the
fluorescent product, i.e. 4-methylumbelliferone, and its
fluorescence is measured as a function of time. The method
of enzyme activity determination described in this paper was
adapted for flow measurements in the microdevice. The curve
ofthe enzymatic reactionadvancement was preparedfor three
reaction times obtained from application of different flow
rates of solutions introduced to the microsystem. Afterwards,
determined β-glucocerebrosidase activity was recalculated
with regard to 10
5 cells present in samples used for the tests.
The obtained results were compared with a cuvette-based
measurements. The lysosomal β-glucosidase activities
determined in the microsystem were in good correlation
withthevaluesdeterminedduringmacro-scalemeasurements.
Keywords Cell lysis.Sheath flow.Optical detection.
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1 Introduction
Microbioanalytics is an interdisciplinary domain in the
midst of chemistry, medicine, molecular biology and
engineering. Recently, this discipline has become very
stimulating for many research groups and it is still
developing. Due to miniaturization and microbioanalytical
achievements many experiments are feasible at the cellular
level and they provide important information for better
understanding of processes investigated. Almost every
significant life process is dependent on enzyme activity
(Ville et al. 1998). Enzymes are biological catalysts
responsible for supporting nearly all of the chemical
reactions in cells that maintain animal homeostasis. Enzyme
assays have become key elements in clinical diagnostics
because of their role in maintaining life processes (Berg et
al. 2001). Extraction of enzymes from cells is fundamental
for many bioanalytical procedures, for example when a
substrate used for an enzymatic reaction does not penetrate
cell membranes. Thus, cell lysis process is necessary to be
performed. It is needed in most cell biology techniques to
extract not only intracellular components such as proteins
but also DNA and RNA (Elizabeth et al. 2002).
Animal cell lysis leads to disintegration of the plasma
membrane which is the barrier separating cell contents from
the environment. There are many different methods of cell
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cal (Brown and Audet 2008). These methods were
successfully applied in microfluidic systems. However, the
choice of lysis protocol depends on the assay and careful
selection of the proper lysis technique are essential for
gathering accurate data from analyzed sample containing
cell suspension. Thermal cell lysis is commonly used as a
preparatory step in nucleic acids analysis based on PCR
(polymerase chain reaction). He et al.(2001) described an
integrated monolithic microchip device which used thermal
cycling to accomplish E. coli lysis and PCR amplification
of DNA. However, the thermal lysis is not ideal for protein
extraction because of their denaturation at high temperature.
Electrical cell lysis is based on electroporation process
which causes formation of small pores in the cell membrane
and makes it permeable to external medium. An example of
the microdevice for the electrical lysis was demonstrated by
Wang et al. (2006). Due to its speed and reagentless
procedure the interest in electrical lysis of cells on a
microfluidic platform has increased recently. Mechanical
methods of cell lysis are also relatively effective and
reagentless. Most of them take advantage of shear stress
phenomenon to disrupt cells. Kim et al. (2004)u s e d
spherical particles in microfluidic CD platform (Compact
Disc) and performed the lysis process with the efficiency of
approximately 65%. However, it is difficult to apply
mechanical lysis for a single cell analysis.
Chemical methods, which disrupt cell membranes using
detergents, solvents and antibiotics, are also widely used for
lysis (Sethu et al. 2004; Carlo et al. 2005). Lytic agents
effectively incorporate into cell membrane and form mixed
micelles with isolated phospholipids and membrane pro-
teins (le Maire et al. 2000). Ocvirk et al. (2004) designed a
Y-shape microchannel to perform the cell lysis within 30 s
using mild, non-ionic Triton X-100, and within 2 s using
ionic sodium dodecyl sulfate (SDS). The cell lysis using
SDS is simple, fast and high-throughput. However, it has
some limitations because SDS denaturates proteins and
interferes with subsequent biological assays. Selection of
proper cell lysis buffer highly depends on assays per-
formed. In case of intracellular components’ examinations
the non-denaturing cell lysis buffer containing Triton X-100
as a main constituent is the most widely used. The cell lysis
process is usually the first step in medical diagnostics
procedures, which enables the determination of wide range
of therapeutic biomarkers, e.g. substrate concentration,
gene expression and enzyme activity.
Currently more than 3000 congenital metabolic diseases
are known, for example: mitochondrial (Thorburn 2004),
peroxisomal (Shimozawa 2007), lysosomal (Ashok 2005)
etc. Most of them are caused by the abnormal value of
enzyme activity. Gaucher’s disease (GD) is the most
common of the lysosomal storage disorders (LSDs) caused
by the deficiency of β-glucocerebrosidase (lysosomal β-
glucosidase, β-Glc) (EC 3.2.1.42), the enzyme that partic-
ipates in the degradation of glycosphingolipids (Grabowski
and Horowitz 1997). This enzyme is characterized by the
accumulation of glucocerebroside in liver, spleen and
bones. The prevalence of GD in the population has been
estimated at about 1:50000 (Grabowski 2008). GD is
relatively common among Ashkenazi Jews, occurring in
about 1:500 people (Beutler et al. 1993). There are three
clinical subtypes of GD that are inherited as autosomal
recessive traits. Type I Gaucher’s disease (non-neuro-
nopathic) is the most popular form. Patients can experience
hepatosplenomegaly, anemia, thrombocytopenia, and bone
abnormalities. Expression of these symptoms is extremely
variable. Some individuals are devastated by the disease
processes in the first decade of life. Type II (acute
neuronopathic) is characterized by such neurologic symp-
toms as muscles hypertonicity and persistent retroflexion.
Patients have extensive and progressive brain damage
usually before they reach the age of two. Finally, patients
with the third type of Gaucher’s disease (Type III—
subacute neuronopathic) show broad spectrum of clinical
symptoms, generally including organomegaly and some
neurologic dysfunction. Highly effective enzyme replace-
ment therapy is available for most patients with types I and
III of GD. This therapy causes decrease of liver and spleen
size, reduction of skeletal anomalies, and successfully
reverses other symptoms of the disorder. In principle,
plasma, leukocytes and skin fibroblasts are mainly utilized
for the enzymatic diagnosis. Beutler and Grabowski (2001)
found out that individuals with GD show 10% of the
normal activity of β-Glc.
Unfortunately, there is still a problem with diagnostics of
heterozygote patients. They have half-normal enzyme
activity, but there is an overlap with non-affected controls.
Molecular analysis seems to be the best diagnosis method.
However, there is a large number of mutations of gene
coding β-Glc. Thus, it renders the biochemical study on the
enzyme activity more accessible (de Fost et al. 2003).
Nowadays, there are many approaches for screening of
various LSDs. Different methods including spectrophoto-
metric, fluorometric, radiometric, mass spectrometric or
immunological assays have been used to determine intra-
cellular proteins (Gelb et al. 2006). There is still no ideal
biochemical screening method for newborns suffering from
LSDs, especially for heterozygotes patients. There are large
number of false-positive and false-negative results (Meikle
et al. 2004). Each of currently applied methods has
advantages and drawbacks and the choice of the method
very often depends on clinical laboratory capabilities and
personnel. Mass spectrometric and immunological assays
are multiplexable. They may provide information on many
proteins present in one sample, what very often reduces the
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complicated. The mass spectrometry seems to be powerful
in clinical diagnostics of LSDs (Gelb et al. 2006; la Marca
et al. 2009). It is extremely sensitive and repeatable
technique. However, MS instruments are expensive and
are still not widely used in clinical laboratories. Moreover,
the short time of analysis with MS concerns only the
detection step. The rest of steps such as: cell suspension
preparation, performing of enzymatic reactions, or sample
incubation, take even several hours. Spectrophotometric
or fluorimetric methods are commonly used in many
clinical laboratories and hospitals. Although they are not
excellent for screening tests, they are appropriate to
examine one protein at the time, and in fact to diagnose
many of patients with the abnormal value of intracellular
enzymes’ activities.
Development of novel, effective diagnostic strategies
and procedures, based on intracellular components analysis,
is strongly related with applying micro total analysis
systems (μTAS). Apart from low reagents consumption,
short reaction time, integration, automation, versatility,
possibility of diagnostic monitoring and stimulation of
each step of the procedure, the use of miniaturized micro-
devices in progressive clinical medicine (point of care
systems, POCS) affects the patients’ comfort (Figeys and
Pinto 2000; Kutter 2000).
In this study we describe an integrated microsystem with
optical detection for intracellular components analysis.
Nowadays there are many approaches to determine the
level of cellular compounds (Hadd et al. 1997; Clark et al.
2009), especially to perform enzyme assays (Wang 2002).
Most of them are sensitive and have low detection limits.
Unfortunately, many microfluidic chips described in the
literature are combined with expensive and complicated
instruments, e.g. de Boer et al. (2005) described a micro-
system for bioactivity screening combined with capillary
liquid chromatography and mass spectrometry. In many
cases, before the actual analysis in a microsystem, the
incubation of biological material with a substrate is
required. This process may take even a few hours, which
significantly extends the time of analysis. The goal of this
work is to develop an easy to handle, cheap and versatile
microsystem with a sensitive detection method. Apart
from these advantages, the microsystem enables to
perform enzymes activity determination just after cell
lysis process. It significantly improves the quality of the
results because there is a limited effect of proteases
released during the lysis process on the analyzed enzymes.
Brief description of investigations on the microsystem for
intracellular enzyme activity analysis was reported previ-
ously (Chudy et al. 2009). In this paper, all details
concerning the microdevice’s fabrication and measurements
of β-Glc in L929 fibroblasts are presented. Moreover, the
next cell culture, A549 epithelial cells were investigated.
After the validation of developed β-Glc activity determi-
nation method using fibroblasts from patients suffering
from GD and control group, the presented microfluidic
device will be ready for preliminary tests in clinical
laboratories.
2 Experimental
2.1 Microdevice fabrication
Nowadays, there are several technologies for microsystems’
fabrication using polymers. We decided to use the photo-
lithography and the replica molding technique for PDMS
structures preparation (McDonald et al. 2000). Details of
the technology applied are given by Juchniewicz et al.
(2009) therefore only a brief description is given in this
paper. The first step of the microdevice structure fabrication
was the preparation of a replica using capillary films. The
capillary film is a UV sensitive emulsion precisely
deposited on a flexible polyester foil. The thickness of the
emulsion depends on the type of capillary film, and varies
between 15 and 700 μm( www.chromaline.com). In our
case, the Pro/Cap 50 (Chromaline) Capillary Film with
50 μm thick emulsion layer was used. It means that using
this type of a capillary film we are able to fabricate 50 μm
high patterns for microchannels’ replication in PDMS. A
piece of the capillary film was attached to a solid support
(PMMA, glass, etc.) and exposed with UV light through a
photomask. UV exposure of the photosensitive layers can
be performed with the use of various types of photo-
masks. The most precise patterns are obtained using glass/
chromium photomasks. However, in our case hi-res laser
printed foil with the negative of the microchannels’
network was sufficient for 50 μm structures replication
in PDMS. The exposed photosensitive layer was devel-
oped using water stream and it was dried using com-
pressed nitrogen. In this way, a mold with a designed
geometry for the structures’ replication in PDMS was
obtained. Degassed mixture of PDMS prepolymer with
curing reagent with 10:1 weight ratio was poured into the
mold and it was subsequently cured for 1 h at 60°C. The
whole fabrication procedure took only 2 h and the PDMS
plate with precisely formed microchannels’ network was
obtained. The PDMS slab with the microchannels was
immersed into liquid nitrogen and then the inlet and outlet
holes for tubings were drilled. The next step of the
fabrication procedure was microchannels’ sealing using a
plain PDMS slab. After cleaning with distilled water, both
slabs were placed in a laboratory dryer at 70°C for 10 min
and then exposed to oxygen plasma for 35 s (Plasma
Preen System Inc. II 973). The plates were manually
Biomed Microdevices (2011) 13:431–440 433aligned, immediately put together and left for 2 h for
bonding.
The microdevice was fabricated using PDMS (Dow
Corning Sylgrad 184) as a material, because of its chemical
inertness, non-cytotoxicity and biocompatibility (Mata et al.
2005). The transparency of PDMS enables microscope
observation of the cell lysis process. Moreover, its
hydrophobicity minimizes the risk of microchannels clog-
ging by biological material used in analytical procedures.
2.2 Microdevice geometry
A schematic view of the integrated microdevice is presented
in Fig. 1. The design of chemical cell lysis module is based
on the sheath flow geometry (Hoffman et al. 2001). The
goal of applying the sheath flow in the microdevice is to
obtain a maximum efficiency of cell lysis process. There
are three microchannels (each 120 μm wide and 50 μm
deep), i.e. two side-focusing streams used for lysis buffer
and the middle one for cell suspension and substrate
mixture introduction. These three microchannels merge
into a single channel and form a meander-shape micro-
reactor (a length of 1 m, a width of 300 μm and a depth of
50 μm), in which the lysis process and the analytical
enzymatic reaction undergo simultaneously.
The enzyme/substrate reaction runs in the microreactor.
A length of 1 m of the microreactor is sufficient for
effective fluid mixing and enough for detection of different
fluorescent product’s concentrations obtained by precise
adjusting of solutions’ flow rates (see Section 11).
2.3 Optical fibers
Measurements offluorescent4-methylumbelliferone(4-MU)
released from lysed cells were carried out by quartz
optical fibers (a diameter of 0.6 mm) connected with a
spectrofluorimeter (FluoroMax-3, Jobin Yvon Inc.).
Although it was obligatory to use a quartz optical fiber
for transmission the excitation light (λex=320 nm), using a
quartz optical fiber for detection was unnecessary. A
detection quartz optical fiber could be replaced with a silica
optical fiber, but then fluorescence background is signifi-
cantly higher. Quartz optical fibers were perpendicularly
inserted into guiding microchannels. The distance between
microchannel and each optical fiber in the detection zone
was 600 μm.
2.4 Reagents and solutions
Cells were lysed by the use of non-denaturing cell lysis
buffer (pH 5.4) containing 10 mM imidazole (Fluka), 0.5 M
sodium chloride (Fluka), 1% Triton X-100 (Sigma Aldrich),
0.2 mM sodium ortho-vanadate (Sigma Aldrich) and
0.2 mM phenylmethylsulfonyl fluoride (PMSF, Fluka)
dissolved in 100 ml of DI water. The enzymatic reaction
was initiated by the addition of the synthetic substrate
4-methylumbelliferyl-β-D-glucopyranoside (MUG, Fluka)
dissolved in 0.2 M sodium acetate buffer (pH 5.4) to the
final concentration of 3 mM. 0.6% sodium taurocholate
solution (ST) (Sigma Aldrich) was added to the reaction
mixture to inhibit cytosolic and activate lysosomal β-
glucosidase (Peters et al. 1976).
2.5 Cells
L929 mouse fibroblasts and A549 human lung adenocarci-
noma cells (American Type Culture Collection) were used
as the model cells for the analytical method optimiza-
tion and evaluation. The culture medium for routine
culture contained: 88.9%vol Minimum Essential Medium
Eagle (MEME, Sigma Aldrich), 10%vol Fetal Bovine
Serum (FBS, Gibco), 1%vol 25 mM L-glutamine (Sigma
Aldrich) and 0.1%vol 100 mM penicillin and streptomycin
(Sigma Aldrich).
The cells were cultured in a CO2 cell culture incubator
(HERAcell 150, Thermo Scientific) at 37°C and in the 5%
CO2atm. The cells were passaged every 2 days. In order to
prepare cell suspension the medium was removed from the
culture flask and the cells were rinsed with PBS buffer
(Phosphate Buffered Saline, Sigma Aldrich). Next, the cells
were trypsinized using 0.25% trypsin in EDTA (Sigma
Aldrich). The detached cells were suspended in pure
MEME medium. The target cell density was about
10
6 cells/mL.
Propidium iodide (PI, Sigma Aldrich) was used as a dye
staining necrotic cells. The solution of 1 mg of PI in 1 mL
of PBS was added to culture medium to achieve concen-
tration of 40 μg/mL. Fig. 1 Schematic view of integrated microsystem
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The enzyme activity measurement method developed by
Peters et al. (1976) was modified and applied in micro- and
macro-scale set-ups. In Peters’ method a mixture of lysed
leucocytes, MUG and sodium taurocholate dissolved with
acetate buffer were incubated at 37°C for 30 min. After
incubation the enzymatic reaction was stopped by adding
glycine-NaOH buffer (pH 10.5), causing β-Glc inactiva-
tion. The amount of 4-MU released in the reaction was
determined spectrofluorimetrically in alkaline pH (deproto-
nated form of 4-MU was measured). In the modified
method (proposed in this paper) the enzyme/substrate
reaction was not stopped by the glycine-NaOH buffer
addition. In consequence the fluorescence intensity of
protonated form of 4-MU was measured using the
spectrofluorimeter at wavelength λem=445 nm after 4-MU
excitation at wavelength λex=320 nm. Macro-scale experi-
ments were performed for verification and evaluation of the
proposed microdevice design and the flow-through micro-
scale method of β-Glc activity determination.
2.6.1 Macro-scale measurement
The reaction mixture (total volume at 3.55 mL) placed in a
quartz cuvette contained: 0.5 mL cell suspension (10
5–10
6
cells), 50 μL of cell lysis buffer, 21 mg sodium taurocho-
late, and MUG dissolved in 3 mL of 0.2 M acetate buffer
(pH 5.4). Total concentration of MUG in the prepared
reaction mixture was 3 mM. The fluorescence spectrum
of MUG and 4-MU is presented in Figs. 2 and 3,
respectively. The β-Glc activity was calculated using the
slope value of the measured advancement reaction curve
(i.e. C4-MU=f(time)) at 22°C. In order to obtain the enzyme
activityinμU/10
5 cells, where 1 U means amount of μmoles
of substrate converted per 1 min [U=μmol min
−1], following
calculations were performed:
Ab Glc ¼ X   a   8 ð1Þ
where:
Ab-Glc enzyme activity in μU/10
5 cells
X=6·10
10 factor to convert mol·dm
−3·s
−1 to μU·mL
−1
a slope value in mol·dm
−3·s
−1 of C4-MU=f(time)
curve
8 cell density factor, giving the value of enzyme
activity counted per 10
5 cells
8 ¼ 105=Dc ð1aÞ
where:
Dc cell density (number of cells in 1 mL of the
reaction mixture)
2.6.2 Micro-scale measurement
Micro-scale measurements of β-Glc activity were carried
out in the presented microdevice (Fig. 4) with perpendic-
ularly mounted optical fibers used for optical detection. The
volume of the analysed reagents mixture in the optical
fibers detection zone (see Fig. 1) is 7.5 nL. Two syringe
pumps were used to introduce the solutions in 1:4 flow rate
ratio into the microsystem. Solution dosed by the first
syringe pump contained cell suspension (10
5–10
6 cells/mL)
(see Fig. 4a), 105 mg sodium taurocholate and 15 mM
MUG dissolved in 0.2 M sodium acetate buffer (pH 5.4).
The second syringe pump (with 4-fold higher flow rate than
the first one) was used for dosing non-denaturing cell lysis
buffer (pH 5.4). The amount of 4-MU released in the
enzyme/substrate reaction is strictly dependent on the
duration of this reaction. In order to determine the
advancement reaction curve and calculate the β-Glc
activity, the enzymatic reaction was carried out for different
reaction times: 60 s, 90 s, 120 s. These reaction times were
Fig. 2 The fluorescence spectrum of MUG
Fig. 3 The fluorescence spectrum of 4-MU
Biomed Microdevices (2011) 13:431–440 435obtained by applying different flow rates with constant ratio
of solutions introduced into the microsystem. The activity
of β-Glc in micro-scale was calculated similarly to macro-
scale using the (1) equation.
3 Results and discussion
3.1 Sheath flow parameters optimization
In order to obtain highly efficient chemical lysis process in
the microsystem, instead of a Y-shaped microchannel, a
hydrodynamic focusing was applied. A sheath flow
geometry enables immediate contact of each introduced to
the microchannel cell with the lysis buffer. The diameter of
L929 fibroblast and A549 epithelial cells used in experi-
ments is approximately 12–13 μm and it is also the desired
width of the middle stream with the cell suspension. The
flow rates ratio of fluids introduced into the microdevice
determines the width of the streams. Thus, they were
investigated and optimized (see Fig. 5). Comsol Multi-
phisics 3.3 software was used for flow rates simulations of
focusing process (see columns C and D). In simulations the
Navier–Stokes equation for incompressible fluids and the
Fick’s second law for mass transport between phases were
used. It can be seen in Fig. 5/column D, that due to the
diffusion the stream is tapered. To obtain comparable data,
the width of the stream was measured in the zone of cell’s
first contact with the cell lysis buffer (normalized c=0.8).
Obtained results were verified by the measurements of
fluorescence intensity profiles in streams’ junction zone
(Fig. 5/column E). The required middle stream’s width of
15 μm was obtained by applying flow rates of the lysis
buffer and cell suspension/substrate mixture in the ratio
of 4:1.
3.2 Preliminary macro-scale experiments
The first step of our investigations was to perform the cell
lysis process, which is essential in different cell analysis.
This process was studied by the microscopic observation of
cells’ morphology after their treatment with non-denaturing
cell lysis buffer (see Fig. 6). The changing shape of cells
and membrane disruption were possible to perceive. In
order to confirm the microscopic observations the fluores-
cent test with the PI as a dye was performed. PI intercalates
nucleic acids of necrotic cells and gives red fluorescent
light, when the sample was excitated with a lex=535 nm.
Different volumes of the lysis buffer in the range of
5–200 μL were added to the cell culture flasks containing
5 mL of cell suspension (approximately 10
6 cells/mL). The
volume of 80 μL of the cell lysis buffer was determined as
a minimal to perform rapid and effective cell membrane
disintegration.
The next step was to study the influence of the
mixture ingredients on the fluorescence intensity during
measurements of enzyme activity (Fig. 7). Elimination of
some ingredients from the mixture consisted of L929
fibroblasts (or A549 epithelial cells), substrate MUG,
sodium acetate buffer, cell lysis buffer and the detergent—
sodium taurocholate, allowed to estimate their effect on the
detectedsignal.ForthemixturewithoutMUG(Fig.7/curve A)
the fluorescence intensity was not changing. Obtained low
and stable signal indicates that, except of MUG, the other
ingredients are not fluorescent. In case of cells’ exclusion
from the reaction mixture (Fig. 7/curve B) the increase of
Fig. 4 A photograph of inte-
grated microsystem. Picture A
shows the cell suspension
introduced to microchannel.
Picture B shows the one cell
focused in the sheath flow zone
and picture C shows necrotic
cells dyed with propidium
iodide
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indicates that MUG does not hydrolyze spontaneously in
solutions applied: lysis and sodium acetate buffers. Only
slight increase in the fluorescence intensity was observed for
the mixture that did not contain the cell lysis buffer (Fig. 7/
curve C). It is a proof that some cells present in the cell
suspension used in the experiments were disrupted. It was
also proved using PI as a dye for necrotic cells, that about 8%
of total amount of the cells after passage is disintegrated.
Moreover, UV light applied for 4-MU excitation during the
measurements may also harmfully affect the cells. To prove
our hypothesis additional experiment was carried out. PI was
added to the cell suspension and the increase in necrotic cells
number was observed for half an hour. It was calculated that
about 5% cells died after this time. It explains the increase in
the fluorescence intensity in time. The difference in slope
values of the measured curves of the mixture without the cell
lysis buffer and the reaction mixture contained all ingredients
(Fig. 7/curve D) indicates that MUG does not penetrate the
cell membrane and the cell lysis is the necessary process to
perform in order to determine β-Glc activity.
3.3 Measurement of β-glc activity in a macro-scale
In order to calculate β-glucocerebrosidase activity, the
slope value of the measured advancement reaction curve
(i.e. C4-MU=f(time)) was determined (see Experimental
Section). Enzyme activity assays were performed 5 times,
each assay for fresh prepared stock cell suspension
(Table 1). The limit of detection (LOD), determined by the
concentration thatgavea signal3 times the standarddeviation
of the blank, was 5 μM for 4-MU. The calculated β-Glc
activity in L929 fibroblasts at 22°C was 110.2 μU/10
5 cells
and the standard deviation was less than 20%, whereas in
A549 epithelial cells was 34.6 μU/10
5 cells with the
standard deviation of this value also less than 20%. The
obtained results were used as reference values to compare
with the results obtained in a micro-scale.
3.4 Measurement of β-glc activity in a micro-scale
In comparison with the methods conventionally used to
determine the β-Glc activity, the one of the most important
Fig. 5 Sheath flow parameters
optimization—simulation and
experiments results comparison
Biomed Microdevices (2011) 13:431–440 437advantages of the presented microdevice is performing of
enzymatic reaction just after cell lysis process. Released
enzyme molecules to the reagent mixture react with an
excessive amount of MUG (the enzymatic reaction must be
independent of the substrate concentration). Although
reagents mixture contains protease inhibitors, the possibility
of inhibiting some β-Glc molecules by proteases after cell
lysis process is minimized. It is extremely important to
avoid inactivation of the determined enzyme, especially,
when it is hard to classify an individual to one of patients or
carriers group.
The elaborated method of β-Glc activity measurement in
the presented microsystem is based on determination of the
fluorescence intensity of 4-MU for different enzymatic
reaction times. The time of the enzymatic reaction for
changed flow rates was estimated using two independent
methods. The first one was based on calculations with
parameters such as: dimensions of the microchannel and
total flow rate of introduced to the microchip reagents. The
second one was based on measurement of time of series
microbubbles purposely introduced into the microchannel.
Results obtained in both methods were in accordance with
one to another. Times of 60 s, 90 s, 120 s were obtained for
total fluid flows of 20 μL/min, 15 μL/min and 10 μL/min,
respectively. Additionally, it was stated that the cell suspen-
sion/substrateflowratecannotbelessthan2 μL/min,because
below this value, the cells agglomerate in the inlet chamber
causing microchannels’ clogging. The curve of advancement
of the enzymatic reaction (Fig. 8) was estimated for three
different reaction times obtained by the change of substrates’
flow rates were kept in the constant 4:1 ratio. Application of
more than three different reaction times was not necessary. It
was checked that measurements of β-Glc activity at higher
Fig. 7 Preliminary macro-scale experiments. Curves show: a fluores-
cence response of the mixtures: without MUG (a), without fibroblasts
(b), without the cell lysis buffer (c), and a reaction mixture containing
all ingredients (d)
Fig. 6 A microscopic observa-
tion of the lysis process of L929
fibroblasts using a non-
denaturing cell lysis buffer
(100 μL of a cell lysis buffer
was added to 1 mL of cell
suspension), and FDB and
PI as fluorescent dyes.
Picture (A)—cell suspension
without a lysis buffer;
picture (B)—after 10 s;
picture (C)—after 20 s; picture
(D)—after 30 s
438 Biomed Microdevices (2011) 13:431–440number of reaction times caused longer analytical procedure
and did not improve precision of the method presented.
Determination of the β-Glc activity in a micro-scale was
performed for 5 samples from different stock cell suspen-
sions (Table 1). The limit of detection (LOD) of the micro-
scale fluorescence-based enzyme assay was 20 μMf o r
4-MU. The calculated lysosomal β-glucosidase activity in
L929 fibroblasts was 95.0 μU/10
5 cells with the standard
deviation about 15%, whereas in A549 epithelial cells was
24.4 μU/10
5 cells with the standard deviation about 25%.
Although the cell suspension density was estimated using
cell counting chambers the enzyme activity determination
method had to be supported by the microscope observations.
Our further researches will be focused on development of a
miniaturized cell cytometer that could resolve this problem
and make this method independent of using a microscope.
Moreover, the integration of the presented microdevice with
temperature control system could make this method even
more precise.
Comparison or verification of our results of β-Glc
activity determination with the results obtained by other
research groups that can be found in the literature is
impossible. There is a lot of factors influencing the enzyme
activity determination such as: source of enzyme, temper-
ature, pH of used buffer solutions, addition of activators or
inhibitors of intracellular isoenzymes, and even type of
medium used for the cells’ cultivation. Beutler et al. (1971)
studied the β-glucosidase activity in fibroblasts from
homozygotes and heterozygotes and they obtained 2.7-fold
higher level of enzyme activity with MEM medium than
with F-12 medium. It is a proof that the obtained results of
the enzyme activity are highly related to used method and
conditions in which assays were performed. One way to
verify the method developed is to perform this method
validation. Then, the β-Glc activity determination with
different diagnostic methods using the same biological
material from individuals and patients with GD should be
performed.
4 Conclusions
The purpose of this work was to design and develop an
integrated microdevice with optical detection for intracel-
lular components analysis directly after cell lysis process.
Following procedures described in the literature a novel
approach was developed and its practical application in
miniaturized systems was found. The usability of the
microsystem presented was verified by performing assays
of β-glucocerebrosidase activity in two different cell lines:
L929 fibroblasts and A549 epithelial cells. The obtained
results of β-Glc activity in a micro-scale were in good
agreement with cuvette-based measurements. After the
validation of the analytical procedure using fibroblasts
from patients suffering from Gaucher’s disease and control
group the presented microsystem could be used for
preliminary tests in clinical laboratory. Currently, there is
no biochemical/enzymatic method that reliably identifies all
carriers of Gaucher’s disease. The degree of misclassification
of obligate heterozygotes is unacceptably high, reaching even
35% of all of the currently available β-Glc assays. New
approaches to calculate β-Glc activity and classification of
people to right group of patients are still explored. The
Fig. 8 The curve of the enzymatic reaction advancement measured in
the microsystem
Table 1 Results of β-Glc activity determination
Cell line Scale Enzyme activity
[μU/10
5 cells]
Average enzyme
activity [μU/10
5 cells]
L929 Macro 86 110.2±19.6
114
131
126
94
Micro 90 95.0±15.0
90
75
112
108
A549 Macro 45 34.6±6.3
32
36
29
31
Micro 16 24.4±6.2
20
27
28
31
Biomed Microdevices (2011) 13:431–440 439presented microdevice should be appropriate for diagnostics
of GD, as well as other LSDs, which diagnostic procedures
are similar to those for GD. We hope that it will be an
alternative for commonly applied and quite expensive disease
diagnosis procedures utilized only in few clinical laboratories
in Europe. Our further research will be focused on determin-
ingotherintracellularcompounds,integrationofacellcounter
system and a temperature control system in the microdevice.
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